JP2020502104A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502104A5 JP2020502104A5 JP2019531589A JP2019531589A JP2020502104A5 JP 2020502104 A5 JP2020502104 A5 JP 2020502104A5 JP 2019531589 A JP2019531589 A JP 2019531589A JP 2019531589 A JP2019531589 A JP 2019531589A JP 2020502104 A5 JP2020502104 A5 JP 2020502104A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- chain
- protein
- selenocysteine
- residues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022184852A JP7378106B2 (ja) | 2016-08-30 | 2022-11-18 | ゲノム的に再コードした生物におけるセレノ－生物製剤の製造 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662381316P | 2016-08-30 | 2016-08-30 | |
| US62/381,316 | 2016-08-30 | ||
| US201762537986P | 2017-07-28 | 2017-07-28 | |
| US62/537,986 | 2017-07-28 | ||
| PCT/US2017/049354 WO2018045018A1 (en) | 2016-08-30 | 2017-08-30 | Production of seleno-biologics in genomically recoded organisms |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022184852A Division JP7378106B2 (ja) | 2016-08-30 | 2022-11-18 | ゲノム的に再コードした生物におけるセレノ－生物製剤の製造 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020502104A JP2020502104A (ja) | 2020-01-23 |
| JP2020502104A5 true JP2020502104A5 (cg-RX-API-DMAC7.html) | 2020-10-08 |
| JP7186400B2 JP7186400B2 (ja) | 2022-12-09 |
Family
ID=61301655
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531589A Active JP7186400B2 (ja) | 2016-08-30 | 2017-08-30 | ゲノム的に再コードした生物におけるセレノ－生物製剤の製造 |
| JP2022184852A Active JP7378106B2 (ja) | 2016-08-30 | 2022-11-18 | ゲノム的に再コードした生物におけるセレノ－生物製剤の製造 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022184852A Active JP7378106B2 (ja) | 2016-08-30 | 2022-11-18 | ゲノム的に再コードした生物におけるセレノ－生物製剤の製造 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11492650B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3506945A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7186400B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN109803679A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018045018A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| JP7088454B2 (ja) | 2015-12-30 | 2022-06-21 | コディアック サイエンシーズ インコーポレイテッド | 抗体および抗体複合体 |
| US11542332B2 (en) | 2016-03-26 | 2023-01-03 | Bioatla, Inc. | Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof |
| CN109844105A (zh) | 2016-07-11 | 2019-06-04 | 得克萨斯州大学系统董事会 | 包含硒代半胱氨酸的重组多肽及其产生方法 |
| CN112203679A (zh) | 2018-03-02 | 2021-01-08 | 科达制药股份有限公司 | Il-6抗体及其融合构建体和缀合物 |
| CA3106157A1 (en) * | 2018-07-09 | 2020-01-16 | Gro Biosciences Inc. | Non-standard amino acid containing compositions and uses thereof |
| US20220144915A1 (en) * | 2019-04-19 | 2022-05-12 | The Trustees Of Indiana University | Stabilization of prandial or basal insulin analogues by an internal diselenide bridge |
| WO2021072265A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| IL293450A (en) | 2019-12-03 | 2022-07-01 | Evotec Int Gmbh | Interferon-associated antigen binding proteins and uses thereof |
| JP7735291B2 (ja) | 2020-02-21 | 2025-09-08 | エーアールエス ファーマシューティカルズ、インコーポレイテッド | ネクチン－４抗体コンジュゲートおよびその使用 |
| CN113512116B (zh) * | 2020-04-10 | 2022-09-20 | 苏州普乐康医药科技有限公司 | 一种抗igf-1r抗体及其应用 |
| CN119792512A (zh) | 2020-10-14 | 2025-04-11 | 维里迪安治疗公司 | 用于治疗甲状腺眼病的组合物和方法 |
| US20230084477A1 (en) | 2021-08-10 | 2023-03-16 | Viridian Therapeutics, Inc. | Compositions, doses, and methods for treatment of thyroid eye disease |
| WO2023051680A1 (zh) * | 2021-09-30 | 2023-04-06 | 正大天晴药业集团股份有限公司 | 针对免疫检查点的双特异性抗体 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6849417B1 (en) * | 1998-04-06 | 2005-02-01 | The United States Of America As Represented By The Department Of Health And Human Services | Mammalian selenoprotein differentially expressed in tumor cells |
| WO2001012657A2 (en) | 1999-08-16 | 2001-02-22 | Karolinska Innovations Ab | Methods and means for selenoprotein expression |
| WO2007075438A2 (en) | 2005-12-15 | 2007-07-05 | Codon Devices, Inc. | Polypeptides comprising unnatural amino acids, methods for their production and uses therefor |
| US20090155255A1 (en) * | 2007-09-27 | 2009-06-18 | Biogen Idec Ma Inc. | Cd23 binding molecules and methods of use thereof |
| AU2012216723B2 (en) * | 2007-11-20 | 2014-08-28 | Ambrx, Inc. | Modified insulin polypeptides and their uses |
| MX2010005317A (es) | 2007-11-20 | 2010-06-02 | Ambrx Inc | Polipeptidos de insulina modificados y sus usos. |
| JP5572972B2 (ja) * | 2009-03-16 | 2014-08-20 | Ｊｎｃ株式会社 | インスリン分泌促進剤などの薬物のスクリーニング方法 |
| WO2012031327A1 (en) * | 2010-09-08 | 2012-03-15 | Howard Florey Institute Of Experimental Physiology And Medicine | Modified relaxin polypeptides |
| ES2746559T3 (es) * | 2011-01-28 | 2020-03-06 | Nat Res Council Canada | Modificación genética de dominios de inmunoglobulina |
| EP3527218A1 (en) | 2011-06-10 | 2019-08-21 | Bioverativ Therapeutics Inc. | Pro-coagulant compounds and methods of use thereof |
| US9464288B2 (en) * | 2011-07-11 | 2016-10-11 | Yale University | Compositions and methods for making selenocysteine containing polypeptides |
| US10240158B2 (en) | 2011-07-11 | 2019-03-26 | Yale University | Compositions and methods for making selenocysteine containing polypeptides |
| US10876142B2 (en) | 2011-07-11 | 2020-12-29 | Yale University | Compositions and methods for making selenocysteine containing polypeptides |
| PT2968552T (pt) | 2013-03-14 | 2020-05-18 | Scripps Research Inst | Anticorpo dos agentes alvo, combinações e uso para os mesmos |
| US20150050682A1 (en) | 2013-08-15 | 2015-02-19 | University Of Vermont And State Agricultural College | Direct assay of thioredoxin reductase activity |
| WO2015066543A1 (en) * | 2013-11-01 | 2015-05-07 | Board Of Regents, The University Of Texas System | Targeting her2 and her3 with bispecific antibodies in cancerous cells |
| US10118950B2 (en) | 2014-08-30 | 2018-11-06 | Northwestern University | Platforms for cell-free protein synthesis comprising extracts from genomically recoded E. coli strains having genetic knock-out mutations in release factor 1 (RF-1) and endA |
| WO2016172269A2 (en) * | 2015-04-20 | 2016-10-27 | University Of Utah Research Foundation | Insulin analogs having shortened b chain peptides and associated methods |
| CN105111304B (zh) * | 2015-09-30 | 2018-12-14 | 山东阿华生物药业有限公司 | 重组人胰岛素前体的纯化和酶切转换方法 |
| US10557160B2 (en) | 2015-12-15 | 2020-02-11 | Board Of Regents, The University Of Texas System | Transgenic bacteria with expanded amino acid usage and nucleic acid molecules for use in the same |
| WO2018014091A1 (en) | 2016-07-22 | 2018-01-25 | University Of Utah Research Foundation | Insulin analogs |
| CN109844105A (zh) | 2016-07-11 | 2019-06-04 | 得克萨斯州大学系统董事会 | 包含硒代半胱氨酸的重组多肽及其产生方法 |
| CR20190096A (es) * | 2016-07-22 | 2019-09-16 | Walter & Eliza Hall Inst Medical Res | Análogos de insulina |
| US20220144915A1 (en) | 2019-04-19 | 2022-05-12 | The Trustees Of Indiana University | Stabilization of prandial or basal insulin analogues by an internal diselenide bridge |
-
2017
- 2017-08-30 EP EP17847457.3A patent/EP3506945A4/en active Pending
- 2017-08-30 US US16/329,761 patent/US11492650B2/en active Active
- 2017-08-30 CN CN201780053385.XA patent/CN109803679A/zh active Pending
- 2017-08-30 JP JP2019531589A patent/JP7186400B2/ja active Active
- 2017-08-30 WO PCT/US2017/049354 patent/WO2018045018A1/en not_active Ceased
-
2022
- 2022-11-18 JP JP2022184852A patent/JP7378106B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020502104A5 (cg-RX-API-DMAC7.html) | ||
| CO2020001113A2 (es) | Muteínas de interleucina 21 y métodos de tratamiento | |
| PH12020551317A1 (en) | Anti-cd73 antibodies and methods of use thereof | |
| JP2020503891A5 (cg-RX-API-DMAC7.html) | ||
| JP2014000092A5 (cg-RX-API-DMAC7.html) | ||
| AR095432A1 (es) | Proteínas de unión a antígeno | |
| AR075504A1 (es) | Moleculas de anticuerpos que tienen especificidad para el ox40 humano | |
| JP2020501550A5 (cg-RX-API-DMAC7.html) | ||
| JP2015525217A5 (cg-RX-API-DMAC7.html) | ||
| HRP20231496T1 (hr) | Cistein proteaza | |
| JP2015212284A5 (cg-RX-API-DMAC7.html) | ||
| JP2017538401A5 (cg-RX-API-DMAC7.html) | ||
| JP2018033454A5 (cg-RX-API-DMAC7.html) | ||
| AR075047A1 (es) | Metodos y composiciones en base a la proteina tipo 2 de la toxina shiga. polipeptido purificado. anticuerpo ant-stx2. kit. | |
| UA107330C2 (uk) | Туберкульозний білок rv3616c та його застосування | |
| PE20161221A1 (es) | Anticuerpos de il-21 | |
| FI3452507T3 (fi) | Tau-immuunihoito | |
| CN113366016A (zh) | 抗人白细胞介素5(il-5)单克隆抗体及其应用 | |
| JP2019505567A5 (cg-RX-API-DMAC7.html) | ||
| PH12022550460A1 (en) | Anti-cd96 antibodies and methods of use thereof | |
| JP2015521206A5 (cg-RX-API-DMAC7.html) | ||
| AR099068A1 (es) | Anticuerpo anti-netrina-1 | |
| EP3932418A3 (en) | Peptides for use in promoting transport of glucose | |
| MX381726B (es) | Cadena alfa del receptor de inmunoglobulina e (ige) de alta afinidad de fusion de fragmento cristalizable (fc). | |
| JP2014504297A5 (cg-RX-API-DMAC7.html) |